[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

IT8519251A0 - Composti ad attivita'antiiperlipidemica, loro preparazione e composizioni farmaceutiche che li contengono. - Google Patents

Composti ad attivita'antiiperlipidemica, loro preparazione e composizioni farmaceutiche che li contengono.

Info

Publication number
IT8519251A0
IT8519251A0 IT8519251A IT1925185A IT8519251A0 IT 8519251 A0 IT8519251 A0 IT 8519251A0 IT 8519251 A IT8519251 A IT 8519251A IT 1925185 A IT1925185 A IT 1925185A IT 8519251 A0 IT8519251 A0 IT 8519251A0
Authority
IT
Italy
Prior art keywords
compounds
contain
preparation
pharmaceutical compositions
antihyperlipidemic activity
Prior art date
Application number
IT8519251A
Other languages
English (en)
Other versions
IT1199652B (it
Inventor
Odoardo Tofanetti
Silvano Spinelli
Igino Casciarri
Original Assignee
Boehringer Biochemia Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Biochemia Srl filed Critical Boehringer Biochemia Srl
Priority to IT19251/85A priority Critical patent/IT1199652B/it
Publication of IT8519251A0 publication Critical patent/IT8519251A0/it
Priority to DE8686101064T priority patent/DE3663943D1/de
Priority to AT86101064T priority patent/ATE44024T1/de
Priority to EP86101064A priority patent/EP0192976B1/en
Application granted granted Critical
Publication of IT1199652B publication Critical patent/IT1199652B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
IT19251/85A 1985-01-28 1985-01-28 Composti ad attivita'antiiperlipidemica,loro preparazione e composizioni farmaceutiche che li contengono IT1199652B (it)

Priority Applications (4)

Application Number Priority Date Filing Date Title
IT19251/85A IT1199652B (it) 1985-01-28 1985-01-28 Composti ad attivita'antiiperlipidemica,loro preparazione e composizioni farmaceutiche che li contengono
DE8686101064T DE3663943D1 (en) 1985-01-28 1986-01-27 Compounds having antihyperlipemic activity, processes for the preparation thereof and pharmaceutical compositions containing them
AT86101064T ATE44024T1 (de) 1985-01-28 1986-01-27 Verbindungen mit antihyperlipaemischer aktivitaet, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
EP86101064A EP0192976B1 (en) 1985-01-28 1986-01-27 Compounds having antihyperlipemic activity, processes for the preparation thereof and pharmaceutical compositions containing them

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT19251/85A IT1199652B (it) 1985-01-28 1985-01-28 Composti ad attivita'antiiperlipidemica,loro preparazione e composizioni farmaceutiche che li contengono

Publications (2)

Publication Number Publication Date
IT8519251A0 true IT8519251A0 (it) 1985-01-28
IT1199652B IT1199652B (it) 1988-12-30

Family

ID=11156130

Family Applications (1)

Application Number Title Priority Date Filing Date
IT19251/85A IT1199652B (it) 1985-01-28 1985-01-28 Composti ad attivita'antiiperlipidemica,loro preparazione e composizioni farmaceutiche che li contengono

Country Status (4)

Country Link
EP (1) EP0192976B1 (it)
AT (1) ATE44024T1 (it)
DE (1) DE3663943D1 (it)
IT (1) IT1199652B (it)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2146138A1 (en) * 1971-07-20 1973-03-02 Lafon Labor Alpha omega substd decanes and dodecanes - for lowering blood fat and cholesterol levels
US4021436A (en) * 1974-03-15 1977-05-03 Claudio Cavazza Derivatives of nicotinic acid with amines variously substituted
DE2532420A1 (de) * 1975-07-19 1977-02-03 Boehringer Mannheim Gmbh Phenylessigsaeure-derivate und verfahren zu ihrer herstellung
IT1209788B (it) * 1980-10-21 1989-08-30 Celesio Sonnino Tauro Sostanza ipolipidemizzante (bis-tio-etil-nicotinato)-1,10-decano
IT1168389B (it) * 1981-05-06 1987-05-20 Alfa Farmaceutici Spa Derivati di alcandioli con attivita' ipolipidemizzante,metodi per la loro preparazione e composizioni farmaceutiche che li contengono

Also Published As

Publication number Publication date
DE3663943D1 (en) 1989-07-20
IT1199652B (it) 1988-12-30
EP0192976A1 (en) 1986-09-03
ATE44024T1 (de) 1989-06-15
EP0192976B1 (en) 1989-06-14

Similar Documents

Publication Publication Date Title
IT1214648B (it) 8 alfa-acilamminoergoline,loro preparazione e loro impiego come medicamenti
IT1203816B (it) Disaccaridi,loro preparazione e loro impiego come medicamenti
IT1200095B (it) Composti maftalenici, loro preparazione e loro impiego come medicamenti
IT1161213B (it) Composizioni farmaceutiche ad attivita' antineoplastica
IT8421241A0 (it) Composti ad attivita'antibatterica, procedimento per laloro preparazione e relative composizioni farmaceutiche.
IT1200163B (it) 8alfa-acilamminoergoline, loro preparazione e composizioni farmaceutiche che le contengono
IT8420082A0 (it) Agenti ad attivita'antibroncospastica e composizioni farmaceutiche che li contengono.
IT8320468A0 (it) Nuovi composti ad attivita'antiinfiammatoria, procedimento per la loro preparazione e composizioni farmaceutiche che licontengono.
IT1199949B (it) Diazepinoindoli,loro preparazione e loro impiego come medicamenti
IT8519903A0 (it) Farmaceutiche che li contengono. composti ad attivita'antiaggregante piastrinica, procedimento per la loro preparazione e composizioni
IT8519251A0 (it) Composti ad attivita'antiiperlipidemica, loro preparazione e composizioni farmaceutiche che li contengono.
IT1194677B (it) Composizione farmaceutica ad attivita' antiflogistica,antipiretica e antalgica
IT8520653A0 (it) Composti ad attivita'antibatterica, loro preparazione e composizioni farmaceutiche relative.
IT8721657A0 (it) Eteri e tioeteri ad attivita'terapeutica, loro preparazione e composizioni che li contengono.
IT8424156A0 (it) Composti ad attivita'antibatterica, procedimento per laloro preparazione e composizioni farmaceutiche che li contengono.
IT8519975A0 (it) Composti ad attivita'antiinfiammatoria, procedimento per la loro preparazione e composizioni farmaceutiche che licontengono.
IT8319981A0 (it) Composti ad attivita' antivirale, procedimento per la loro preparazione e composizioni farmaceutiche cheli contengono.
IT8619245A0 (it) Composti ad attivita' mucolitica e composizioni farmaceutiche che licontengono.
IT8520966A0 (it) Composizioni alimentari e farmaceutiche ad attivita'immunostimolante.
IT8519902A0 (it) Composti ad attivita'immunoregolatrice, processo per laloro preparazione e composizioni farmaceutiche che li contengono.
IT8222339A0 (it) Composti ad attivita'calcio-antagonista, metodo per laloro preparazione e composizioni farmaceutiche.
IT8421627A1 (it) Composizione farmaceutica contenente come ingrediente attivo 24,25-diidrossicolecalciferolo
IT8519151A0 (it) Composti ad attivita'antiinfiammatoria e formulazioni farmaceutiche che li contengono.
IT8621113A0 (it) Composti ad attivita'antibatterica, loro preparazione e composizioni farmaceutiche relative.
IT8520432A0 (it) La loro preparazione e composti ad attivita'composizioni farmaceutiche che li antiinfiammatoria, procedimento per contengono.